2 terminated, 1 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
Follow Compazine: new trials by email Literature Review of Compazine trials Research Report on Compazine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients Ondansetron, Dexamethasone, Neurokinin-1 Receptor Antagonist (NK1-RA) - Gynecologic Cancer | Phase 3 | Terminated | University of Michigan Rogel Cancer Center | 62 | 2020-12-28 | 2025-06-18 |
| The CHECK Trial: A Comparison of Headache Treatment in the Emergency Department: Compazine Versus Ketamine Compazine, Ketamine - Headache | Phase 3 | Terminated | Mike O'Callaghan Military Hospital | 5 | 2016-08-01 | 2024-03-04 |
| Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial aprepitant, dexamethasone, granisetron hydrochloride - Nausea | Phase 3 | Completed | Joseph Roscoe | 1021 | 2006-12-01 | 2015-11-10 |
Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Headache (1) · Inflammatory Breast Neoplasms (1) · Nausea (1) · Vomiting (1)
Joseph Roscoe (1) · Mike O'Callaghan Military Hospital (1) · University of Michigan Rogel Cancer Center (1)
United States (3)
Aimee Rolston (1) · Christopher Pitotti, MD (1) · Joseph A. Roscoe, PhD (1)
PMID 22915657, PMID 29033296, PMID 29089172
U10CA037420 (1)